You are here

Meeting Highlights

American College of Cardiology

Walter Alexander

The American College of Cardiology (ACC) 66th Annual Scientific Session, held from March 17 to 19 in Washington, D.C., hosted about 18,500 medical professionals. We present below key sessions featured in the ACC press briefings, with a focus on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, anti-Xa anticoagulants, and a direct thrombin inhibitor.

Author bio: 
The author is a freelance writer living in New York City.
REFERENCE
  • Lipinski MJ, Benedetto U, Escarcega RO, et al. The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis. Eur Heart J 2016;37;(6):536–545.